Predictive Oncology INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Axe Compute Inc. reports a significant net loss for 2025 driven by digital asset volatility, while aggressively pursuing an AI compute and Aethir token treasury strategy.
Predictive Oncology Inc.'s 10-K filing reveals substantial doubt about its ability to continue as a going concern, despite efforts to secure additional funding and a proposed acquisition by Renovaro, Inc.
Predictive Oncology Inc. details the separation agreement with former CFO Robert Myers and files its annual report on Form 10-K, outlining financial results and business operations.